These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 24083670)

  • 1. Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial.
    Kim SJ; Moon GJ; Chang WH; Kim YH; Bang OY;
    Trials; 2013 Oct; 14():317. PubMed ID: 24083670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial.
    Díez-Tejedor E; Gutiérrez-Fernández M; Martínez-Sánchez P; Rodríguez-Frutos B; Ruiz-Ares G; Lara ML; Gimeno BF
    J Stroke Cerebrovasc Dis; 2014; 23(10):2694-2700. PubMed ID: 25304723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke.
    Chung JW; Chang WH; Bang OY; Moon GJ; Kim SJ; Kim SK; Lee JS; Sohn SI; Kim YH;
    Neurology; 2021 Feb; 96(7):e1012-e1023. PubMed ID: 33472925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Extracellular Vesicles in Stroke Patients Treated With Mesenchymal Stem Cells: A Biomarker Analysis of a Randomized Trial.
    Bang OY; Kim EH; Cho YH; Oh MJ; Chung JW; Chang WH; Kim YH; Yang SW; Chopp M
    Stroke; 2022 Jul; 53(7):2276-2286. PubMed ID: 35341320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Intravenous Mesenchymal Stem Cells for Motor Recovery After Ischemic Stroke: A Neuroimaging Study.
    Lee J; Chang WH; Chung JW; Kim SJ; Kim SK; Lee JS; Sohn SI; Kim YH; Bang OY;
    Stroke; 2022 Jan; 53(1):20-28. PubMed ID: 34583525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial.
    Deng L; Peng Q; Wang H; Pan J; Zhou Y; Pan K; Li J; Wu Y; Wang Y
    Transl Stroke Res; 2019 Apr; 10(2):170-177. PubMed ID: 29796934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).
    Mathiasen AB; Jørgensen E; Qayyum AA; Haack-Sørensen M; Ekblond A; Kastrup J
    Am Heart J; 2012 Sep; 164(3):285-91. PubMed ID: 22980293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis.
    Uccelli A; Laroni A; Brundin L; Clanet M; Fernandez O; Nabavi SM; Muraro PA; Oliveri RS; Radue EW; Sellner J; Soelberg Sorensen P; Sormani MP; Wuerfel JT; Battaglia MA; Freedman MS;
    Trials; 2019 May; 20(1):263. PubMed ID: 31072380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke.
    Lee JS; Hong JM; Moon GJ; Lee PH; Ahn YH; Bang OY;
    Stem Cells; 2010 Jun; 28(6):1099-106. PubMed ID: 20506226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
    Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
    Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous Mesenchymal Stem Cells Improve Motor Recovery in Subacute Ischemic Stroke: a Randomized Clinical Trial.
    Jaillard A; Hommel M; Moisan A; Zeffiro TA; Favre-Wiki IM; Barbieux-Guillot M; Vadot W; Marcel S; Lamalle L; Grand S; Detante O;
    Transl Stroke Res; 2020 Oct; 11(5):910-923. PubMed ID: 32462427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous infusion of auto serum-expanded autologous mesenchymal stem cells in spinal cord injury patients: 13 case series.
    Honmou O; Yamashita T; Morita T; Oshigiri T; Hirota R; Iyama S; Kato J; Sasaki Y; Ishiai S; Ito YM; Namioka A; Namioka T; Nakazaki M; Kataoka-Sasaki Y; Onodera R; Oka S; Sasaki M; Waxman SG; Kocsis JD
    Clin Neurol Neurosurg; 2021 Apr; 203():106565. PubMed ID: 33667953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke.
    Honmou O; Houkin K; Matsunaga T; Niitsu Y; Ishiai S; Onodera R; Waxman SG; Kocsis JD
    Brain; 2011 Jun; 134(Pt 6):1790-807. PubMed ID: 21493695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic human umbilical cord-derived mesenchymal stem cells for severe bronchopulmonary dysplasia in children: study protocol for a randomized controlled trial (MSC-BPD trial).
    Wu X; Xia Y; Zhou O; Song Y; Zhang X; Tian D; Li Q; Shu C; Liu E; Yuan X; He L; Liu C; Li J; Liang X; Yang K; Fu Z; Zou L; Bao L; Dai J
    Trials; 2020 Jan; 21(1):125. PubMed ID: 32005282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-in-man mesenchymal stem cells for radiation-induced xerostomia (MESRIX): study protocol for a randomized controlled trial.
    Grønhøj C; Jensen DH; Glovinski PV; Jensen SB; Bardow A; Oliveri RS; Specht L; Thomsen C; Darkner S; Kiss K; Fischer-Nielsen A; von Buchwald C
    Trials; 2017 Mar; 18(1):108. PubMed ID: 28270226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of intrathecal mesenchymal stem cell-neural progenitor therapy in progressive MS: results from a phase II, randomized, placebo-controlled clinical trial.
    Harris VK; Stark J; Williams A; Roche M; Malin M; Kumar A; Carlson AL; Kizilbash C; Wollowitz J; Andy C; Gerber LM; Sadiq SA
    Stem Cell Res Ther; 2024 May; 15(1):151. PubMed ID: 38783390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-mediated Activation of Bone Marrow-derived Mesenchymal Stem Cells in Ischemic Stroke Patients: A Novel Preconditioning Method.
    Moon GJ; Cho YH; Kim DH; Sung JH; Son JP; Kim S; Cha JM; Bang OY
    Cell Transplant; 2018 Mar; 27(3):485-500. PubMed ID: 29774769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke.
    Levy ML; Crawford JR; Dib N; Verkh L; Tankovich N; Cramer SC
    Stroke; 2019 Oct; 50(10):2835-2841. PubMed ID: 31495331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intra-Articular Injection of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis: A Phase IIb, Randomized, Placebo-Controlled Clinical Trial.
    Lee WS; Kim HJ; Kim KI; Kim GB; Jin W
    Stem Cells Transl Med; 2019 Jun; 8(6):504-511. PubMed ID: 30835956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.